There's a new crop of psych meds that work through serotonin receptors, but not in the way you'd expect. They range from antipsychotics like lumateperone (Caplyta) to novel therapies for depression and anxiety like psilocybin and MDMA, as well as a few familiar meds like mirtazapine, trazodone, and quetiapine. Learn how the 5HT-2A receptor strings together their effects in some paradoxical ways.

Published on: 4/27/20

Duration: 28 minutes, 49 seconds

Article Referenced: "Nuplazid: Novel Mechanism, Modest Benefits," The Carlat Psychiatry Report, April 2020

Feedback? Take the podcast survey.